🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Xi’an
Clinical trial register · China

Clinical Trials in Xi’an, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Beijing 5484 Shanghai 3827 Guangzhou 3318 Hangzhou 1812 Wuhan 1343
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Xijing Hospital124 Tang-Du Hospital49 First Affiliated Hospital Xi'an Jiaotong University41 Air Force Military Medical University, China19 Xijing Hospital of Digestive Diseases19
Site location
Beijing5484 Shanghai3827 Guangzhou3318 Hangzhou1812 Wuhan1343
All 613 locations
Target enrolment
to

Trials with a site in Xi’an

504 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Recruiting
Efficacy and Safety of PJ009 in Patients With Short Bowel Syndrome Requiring Parenteral Nutrition
NCT06512584Short Bowel Syndrome
Chongqing Peg-Bio Biopharm Co., Ltd.
Phase 3
72
Beijing, Chongqing, Guangzhou, Changsha, Nanjing, Qingdao, Shanghai, Xi’an
2024-09-03
Recruiting
Clinical Study of Taurine Combined With Neoadjuvant Chemo-Immunotherapy for Treatment of Locally Advanced Gastric Cancer
NCT06128252Gastric Cancer
Tang-Du Hospital
Not applicable
96
Wuhan, Nanjing, Shenyang, Xi'an, Chengdu, Ürümqi, Chongqing, Shanghai
2024-09-01
By invitation
Observational Study for SIR-Spheres Therapy for the Treatment of HCC Patients in China
NCT06712017Hepatocellular Carcinoma (HCC), Hepatocellular Carcinoma Non-Resectable
GrandPharma (China) Co., Ltd.
Observational
100
Guangzhou, Jinan, Xi’an, Beijing, Shanghai
2024-08-22
Active, closed
Evaluate the Efficacy and Safety of Xianglei Tangzu Gao for the Treatment of Wagner Grade II Diabetic Foot Ulcers
NCT06531512Diabetic Foot Ulcer
Oneness Biotech Co., Ltd.
Phase 2/3
120
Jiangmen, Luoyang, Suzhou, Zhenjiang, Shenyang, Xi'an, Hangzhou, Guangzhou
2024-08-16
Active, closed
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
NCT06517758Generalized Myasthenia Gravis
Novartis Pharmaceuticals
Phase 3
146
Hefei, Guangzhou, Shenzhen, Shijiazhuang, Changsha, Suzhou, Xi'an, Xianyang
2024-07-31
Recruiting
CPVI With Modified Linear Ablation Versus CPVI in Patients With Long-standing Persistent Atrial Fibrillation (SINUS)
NCT06516822Long-standing Persistent Atrial Fibrillation, Ablation
The First Affiliated Hospital with Nanjing Medical University
Not applicable
320
Beijing, Guangzhou, Shenzhen, Zhengzhou, Nanjing, Dalian, Jinan, Xi’an
2024-07-31
Recruiting
Intravascular Ultrasound-Guided PCI in Patients With Chronic Kidney Disease
NCT06567938Coronary Artery Disease, Chronic Kidney Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
1,528
Xi'an
2024-07-25
Recruiting
Evaluating Safety, Tolerability and Pharmacokinetic of Multiple Ascending Doses of VV119
NCT06504290Schizophrenia
Vigonvita Life Sciences
Phase 1
40
Beijing, Xi’an
2024-07-16
Not yet open
Clinical Study of Irinotecan Liposome Combination Therapy for Advanced Gastric Cancer
NCT06499610Gastric Cancer
First Affiliated Hospital Xi'an Jiaotong University
Phase 4
44
Xi'an
2024-07-15
Recruiting
Safety and Efficacy of CD19-BCMA Targeted CAR-T Therapy for Refractory Generalized Myasthenia Gravis
NCT06371040Myasthenia Gravis
Ting Chang, MD
Phase 1
9
Xi'an
2024-07-12
Recruiting
To Explore the Efficacy of Sintilimab Combined With Bevacizumab in Rectal Cancer
NCT06808412Rcctal Cancer
xiaohua li
Phase 2
118
Xi'an
2024-07-05
Recruiting
Neoadjuvant Adebrelimab in Resectable SCLC: A Randomized Trial
NCT06485544Small Cell Lung Cancer (SCLC)
Tang-Du Hospital
Phase 2
104
Xi'an
2024-07-01
Recruiting
Exploratory Study With Parallel Controls on the Safety and Efficacy of Neoadjuvant Low Branched-Chain Amino Acid Diet in Combination With Anti-PD-1 Monoclonal Antibody for Stage III Melanoma
NCT07586891Melanoma (Skin Cancer)
Xijing Hospital
Not applicable
80
Xi'an
2024-07-01
Not yet open
Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC
NCT06475755Non-Small Cell Lung Cancer, Anti Angiogenesis
Tang-Du Hospital
Phase 2
178
Xi'an
2024-06-30
Recruiting
Effects of Remote Ischemic Preconditioning on Peripheral Blood Biomarkers in Healthy Adults (EMINENT)
NCT05957523Ischemic Preconditioning
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
80
Xi'an
2024-06-27
Recruiting
Adebrelimab + Apatinib in SCLC Maintenance Therapy
NCT06475209SCLC
Tang-Du Hospital
Phase 2
60
Xi'an
2024-06-20
Recruiting
A Clinical Study Comparing SG301 Plus Pomalidomide and Dexamethasone to Placebo Plus Pomalidomide and Dexamethasone in Relapsed or Refractory Multiple Myeloma Patients
NCT06508983Relapsed/Refractory Multiple Myeloma
Hangzhou Sumgen Biotech Co., Ltd.
Phase 3
360
Beijing, Guangzhou, Luoyang, Zhengzhou, Wuhan, Suzhou, Taiyuan, Xi’an
2024-06-14
Recruiting
Neoadjuvant Chemotherapy in Combination With Toripalimab for HR+/HER2- Breast Cancer (NEOTORCH-BREAST01)
NCT06611813HR+/HER2- Breast Cancer
First Affiliated Hospital of Zhejiang University
Phase 2
30
Hangzhou, Harbin, Hefei, Jinhua, Nanchang, Shanghai, Ürümqi, Xi'an
2024-06-11
Recruiting
Exploring the Characteristics of Epileptogenic Foci in Drug-Resistant Epilepsy Based on Multimodal Imaging Technology
NCT06557720Drug Resistant Epilepsy, Magnetic Resonance Imaging, Electroencephalogram (EEG)
Xijing Hospital
Observational
50
Xi'an
2024-06-11
Recruiting
An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic/Pharmacodynamic (PK/PD) Characteristics of SR604 Injection in Patients With Hemophilia A/B and Congenital Factor VII Deficiency
NCT07644832Hemophilia A, Hemophilia B, Factor VII Deficiency
Shanghai RAAS Blood Products Co., Ltd.
Phase 1/2
76
Changsha, Hefei, Jinan, Lanzhou, Shanghai, Taiyuan, Tianjin, Xi'an
2024-05-31
Recruiting
Prognosis of Patients With Infective Endocarditis and Risk Stratification Value of Biomarkers (ENDEAVOR）
NCT05965362Infective Endocarditis
First Affiliated Hospital Xi'an Jiaotong University
Observational
2,000
Xi'an
2024-05-09
Recruiting
Risk Stratification and New Early Prevention and Treatment Strategies for Patients With Cardiomyopathy (STRENGTH）
NCT06352320Cardiomyopathies
First Affiliated Hospital Xi'an Jiaotong University
Observational
500
Xi'an
2024-05-09
Recruiting
The Study of Huaier Granule in Postoperative Adjuvant Therapy of Resectable Pancreatic Cancer
NCT06368063Pancreatic Cancer Resectable
Xi'an Jiaotong University
Phase 4
642
Xi'an
2024-05-06
Active, closed
A Multi-center, Two-arm, Phase 2 Clinical Study on the Perioperative Treatment of HER2-positive Resectable Esophagogastric Junctional Adenocarcinoma With Nabulimab Combined With FLOT and Trastuzumab VS FLOT Combined With Trastuzumab
NCT06681298Adenocarcinoma of the Esophagogastric Junction, Perioperative Period
xiaohua li
Phase 2
36
Xi'an
2024-05-01
Recruiting
Partial Pressure of Oxygen Control Method in Identification of Intersegmental Plane
NCT06644066Lung Cancer
Tang-Du Hospital
Not applicable
60
Xi'an
2024-05-01
Recruiting
Single-operator Versus Two-operator Technique in Single-balloon Enteroscopy
NCT06280469Single-balloon Enteroscopy, Operation
Shuhui Liang
Not applicable
228
Lanzhou, Zhuhai, Xi'an
2024-05-01
Recruiting
Neoadjuvant Therapy of Darolutamide Plus ADT for High Risk Prostate Cancer
NCT06575257Prostate Cancer
Xijing Hospital
Phase 2
80
Xi’an
2024-05-01
Recruiting
Efficacy of Acupuncture for the Treatment of Parkinson's Disease Related Constipation
NCT06390761Parkinson Disease, Constipation, Non-motor Symptom, Randomized Controlled Trial
Xi'an No.3 Hospital
Not applicable
60
Xi'an
2024-04-30
Recruiting
The Efficacy and Safety of Y-3 Intracalvariosseous Injection Versus Intravenous Injection in the Treatment of Acute Large Hemispheric Infarction
NCT06374667Stroke, Acute Ischemic, Blood-Brain Barrier
yilong Wang
Not applicable
134
Wuhu, Beijing, Tangshan, Xi'an, Tianjin
2024-04-22
Recruiting
Risk Stratification, Early Prevention and Treatment Strategies for Arrhythmogenic Cardiomyopathy
NCT06352307Arrhythmogenic Cardiomyopathy
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,500
Xi'an
2024-04-09
Recruiting
Research on the Potential Mechanisms Underlying the Efficacy Differences in Specific Neoadjuvant Treatment Regimens for Different Subtypes of Breast Cancer
NCT07012720Breast Cancer
Xijing Hospital
Not applicable
71
Xi'an
2024-04-01
Recruiting
Clinical Characteristics of Sleep Disorders in Patients With Ulcerative Colitis
NCT06359808Colitis, Ulcerative, Sleep Quality, Gastrointestinal Microbiome, Autonomic Nervous System Imbalance
Xijing Hospital
Observational
152
Xi'an
2024-04-01
Recruiting
pBFS Guided rTMS Over Cognitive Control Network for ASD
NCT06255535Autism Spectrum Disorder
Changping Laboratory
Not applicable
215
Fuzhou, Baoding, Xi'an, Jining, Linyi
2024-04-01
By invitation
Videodensitometric Angiographic Assessment of AR in the Cath-lab for Intraprocedural Guidance of TAVI in CHINA
NCT06891079Aortic Stenosis
Xijing Hospital
Not applicable
320
Shanghai, Xi'an
2024-03-28
Recruiting
Evaluation of the Water Vapor Thermal Therapy System for the Treatment of Benign Prostatic Hyperplasia
NCT06725212Benign Prostatic Hyperplasia
Medtecx Co Ltd.
Not applicable
126
Hefei, Beijing, Wuhan, Nanjing, Nanchang, Xi'an, Shanghai, Tianjin
2024-03-26
Recruiting
Development and Validation of an Anxiety Disorder Prediction Model for Premature Ejaculation Patients
NCT06677814Premature Ejaculation, Anxiety
Xijing Hospital
Observational
700
Xi'an
2024-03-25
Recruiting
Study on the Therapeutic Effect of Irinotecan Liposomes in Small Cell Lung Cancer
NCT06467786Small Cell Lung Cancer
Tang-Du Hospital
Phase 4
24
Xi'an
2024-03-15
Active, closed
A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors
NCT06257264Breast Cancer, Small Cell Lung Cancer, Ovarian Cancer, Gastric Cancer
BeiGene
Phase 1
103
Beijing, Guangzhou, Harbin, Changsha, Shenyang, Xi'an
2024-03-11
Active, closed
Interventional Ventricular Assist System for PCI in CHIP Patients
NCT06373120High-Risk Percutaneous Coronary Intervention (High-risk PCI), Left Ventricular Assist Devices
Shenzhen Core Medical Technology CO.,LTD.
Not applicable
262
Xi'an
2024-03-04
Recruiting
Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVF
NCT06023602Infertility
Northwest Women's and Children's Hospital, Xi'an, Shaanxi
Not applicable
1,338
Xi'an
2024-02-27
Recruiting
A Study to Assess Safety, Tolerability, and Pharmacokinetics of ABSK112 in Patients With Non-Small Cell Lung Cancer
NCT06225804Non-Small Cell Lung Cancer
Abbisko Therapeutics Co, Ltd
Phase 1
164
Hefei, Fuzhou, Xi'an, Harbin, Zhengzhou, Wuhan, Changsha, Nanchang
2024-02-22
Active, closed
A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
NCT06206837Breast Cancer
Pfizer
Phase 1/2
71
Guangzhou, Wuhan, Xi'an
2024-02-19
Recruiting
Efficacy of Immunosuppressive Therapy for IgA Nephropathy With Stage 3 or 4 CKD
NCT05510323Glomerulonephritis, IGA
Air Force Military Medical University, China
Phase 3
208
Xi'an
2024-02-01
Recruiting
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study
NCT06755541Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases
Phase 3
150
Xi'an
2024-01-30
Recruiting
The Safety and Efficacy Evaluation of Echocardiography-guided Percutaneous Radiofrequency Ablation for Cardiac Tumors: a Single-arm, Prospective, Single-center Clinical Study
NCT06830512Heart Neoplasms
Xijing Hospital
Not applicable
40
Xi'an
2024-01-24
Recruiting
Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis
NCT06231264Ulcerative Colitis
Xijing Hospital
Not applicable
96
Xi'an
2024-01-19
Recruiting
Fenofibrate in Primary Biliary Cholangitis: a Real World Study
NCT06755151Primary Biliary Cholangitis (PBC)
Xijing Hospital of Digestive Diseases
Phase 3
300
Xi'an
2024-01-17
Recruiting
Safety and Efficacy of XJ-Procedure in Patients With Acute Type A Aortic Dissection Surgery
NCT06199401Type A Aortic Dissection, Complication of Surgical Procedure, Aortic Diseases
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
680
Xi'an
2024-01-11
Recruiting
Multi-omics Study for Early Detection of Colorectal Cancer (MOED-CRC)
NCT06220617Colorectal Cancer, Adenomatous Polyps, Adenoma, Advanced Adenoma
Zhejiang University
Observational
3,600
Hangzhou, Guangzhou, Kunming, Nanjing, Xi'an, Zhengzhou
2024-01-11
Recruiting
Cohort Study of Clinical and Neuroimaging Characteristics for BPPV Patients in China
NCT06228196BPPV, Vertigo, Vertigo, Peripheral
First Affiliated Hospital Xi'an Jiaotong University
Observational
150
Xi'an
2024-01-08
Recruiting
Magnetic Resonance Imaging Study on Young and Middle-aged Patients With Cervical Spondylotic Pain
NCT06217029Neck Pain
First Affiliated Hospital Xi'an Jiaotong University
Observational
80
Xi'an
2024-01-06
Recruiting
Optimize First-line Treatment for AL Amyloidosis With t (11; 14)
NCT06192979Amyloidosis; Systemic, AL Amyloidosis
Jin Lu, MD
Not applicable
41
Beijing, Nanjing, Qingdao, Xi’an
2024-01-05
Recruiting
Evaluation of the Safety and Efficacy of Hemophilia A Gene Therapy Drugs
NCT06111638Hemophilia A
Shanghai Xinzhi BioMed Co., Ltd.
Phase 2/3
55
Beijing, Guangzhou, Guiyang, Wuhan, Changsha, Suzhou, Xi’an, Chengde
2024-01-03
Recruiting
Multi Center Observation of Sentinel Skin Graft for Detecting Acute Rejection After Renal Transplantation
NCT05600634Kidney Transplant Rejection, Skin Graft
Second Affiliated Hospital, Zhejiang University, School of Medicine
Observational
24
Xi'an, Hangzhou
2024-01-01
Recruiting
The Efficacy and Safety of the COMBO Endoscopy Oropharyngeal Airway in Gastrointestinal Endoscopy Procedure
NCT06081647Hypoxia, Gastric Polyp, Colon Cancer, Esophageal Cancer
RenJi Hospital
Not applicable
1,200
Nanjing, Nanchang, Jinan, Shanghai, Xi’an, Tianjin, Hangzhou
2023-12-27
Recruiting
A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma
NCT06235229Multiple Myeloma
Gracell Biotechnologies (Shanghai) Co., Ltd.
Phase 1/2
110
Beijing, Hangzhou, Jinan, Shanghai, Shenyang, Wenzhou, Wuhan, Xi'an
2023-12-26
Active, closed
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis：Contezolid, Delamanid and Bedaquiline Cohort
NCT06081361Pulmonary Tuberculosis, Rifampicin-resistant Tuberculosis
Beijing Chest Hospital
Phase 3
186
Beijing, Changsha, Hefei, Jiamusi, Shandong, Xi'an, Xinxiang, Shijiazhuang
2023-12-22
Active, closed
A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo
NCT06118411Vitiligo
AbbVie
Phase 3
614
Beijing, Guangzhou, Wuhan, Xi'an, Jinan, Shanghai, Chengdu, Tianjin
2023-12-19
Active, closed
Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
NCT05991323Prurigo Nodularis
Sanofi
Observational
100
Guangzhou, Xi'an, Jinan, Hangzhou, Wenzhou, Beijing, Shanghai, Shenzhen
2023-12-12
Active, closed
A Clinical Study of TQA3605 Tablets Monotherapy or in Combination With Nucleoside (Acid) Analogues in Treatment Naive and Treated Patients With Chronic Hepatitis B
NCT06150014Chronic Hepatitis b
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1/2
88
Chongqing, Xi'an
2023-12-07
Recruiting
To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.
NCT05925452Active Systemic Juvenile Idiopathic Arthritis
Changchun GeneScience Pharmaceutical Co., Ltd.
Not applicable
290
Beijing, Chongqing, Changsha, Nanjing, Suzhou, Shanghai, Xi’an, Chengdu
2023-12-01
Not yet open
Predictive Value of HBV pgRNA on Long-term Outcomes in Hepatitis B Patients Treated With Antiviral Therapy
NCT05965388HBV, HCC
Wen-hong Zhang
Observational
5,000
Hefei, Fuzhou, Wuhan, Nanjing, Xuzhou, Jinan, Taiyuan, Xi’an
2023-12-01
Recruiting
Baricitinib for Moderate and Severe Traumatic Intracerebral Hemorrhage/Contusions
NCT06065046Traumatic Brain Injury
Tang-Du Hospital
Phase 2
100
Xi'an
2023-11-24
Recruiting
Safety and Efficacy of Remote Ischemic Conditioning for Patients Taking Off-pump Coronary Artery Bypass Grafting
NCT06141525Coronary Artery Bypass Grafting, Remote Ischemic Conditioning, Ischemia-Reperfusion Injury
First Affiliated Hospital Xi'an Jiaotong University
Not applicable
648
Xi'an
2023-11-22
Recruiting
Neoadjuvant Adebrelimab Plus Etoposide and Cisplatin in Neuroendocrine Bladder Carcinoma
NCT06091124Neuroendocrine Carcinoma of the Bladder, Bladder Cancer
RenJi Hospital
Phase 2
22
Nanjing, Xi'an, Shanghai, Chengdu, Tianjin
2023-11-16
Recruiting
Olverembatinib Plus Venetoclax and Dexamethasone for Treatment-naïve Ph+ Acute Lymphoblastic Leukemia
NCT06082934Newly-diagnosed Ph+ Acute Lymphoblastic Leukemia
Xijing Hospital
Phase 1/2
30
Xi'an
2023-11-01
Recruiting
The Effect of Aspirin on Recurrent Acute Pancreatitis
NCT06185621Recurrent Acute Pancreatitis, Prevention, Aspirin
Air Force Military Medical University, China
Not applicable
23
Xi'an
2023-11-01
Recruiting
Predicting Treatment Outcomes in Refractory Constipation Through Brain Connectivity Evaluation
NCT06221722Constipation - Functional, Refractory Constipation, Fluoxetine, fMRI
Xijing Hospital of Digestive Diseases
Observational
150
Yinchuan, Xi'an
2023-11-01
Recruiting
Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV
NCT06001047Benign Paroxysmal Positional Vertigo
Xi'an No.3 Hospital
Not applicable
120
Xi'an
2023-11-01
Recruiting
Clinical Characteristics and Prognosis of Aortic Dissection in China (CLASSIC)
NCT05999188Aortic Dissection
First Affiliated Hospital Xi'an Jiaotong University
Observational
100
Xi'an
2023-10-30
Recruiting
Safety and Efficacy of Post-marketing Transcatheter Aortic Valves in "Real World" Chinese Patients
NCT06257043Aortic Valve Disease Mixed
Xijing Hospital
Observational
3,000
Xi'an
2023-10-30
Recruiting
NGGT006 Gene Therapy for Homozygous Familial Hypercholesterolemia
NCT06125847Homozygous Familial Hypercholesterolemia
First Affiliated Hospital Xi'an Jiaotong University
Phase EARLY_PHASE1
21
Xi'an
2023-10-29
Recruiting
Characteristics of Cardiac Tumor and the Risk Stratification of Subsequent Adverse Events (UNIQUE)
NCT06100328Cardiac Tumor
First Affiliated Hospital Xi'an Jiaotong University
Observational
40
Xi'an
2023-10-26
Recruiting
A Study to Efficacy and Safety of SPH4336 Monotherapy or in Combination With Cadonilimab in Patients With Advanced Solid Tumors.
NCT05944224Advanced Solid Tumors
Shanghai Pharmaceuticals Holding Co., Ltd
Phase 1/2
63
Fuzhou, Guangzhou, Zhengzhou, Wuhan, Changsha, Yongzhou, Shenzhen, Xi’an
2023-10-17
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
NCT06012240Alopecia Areata
AbbVie
Phase 3
1,500
Beijing, Chongqing, Guangzhou, Shenzhen, Wuhan, Nanchang, Changchun, Xi'an
2023-10-11
Recruiting
Zimberelimab Combined With Albumin-bound Paclitaxel and Cisplatin in Neoadjuvant Treatment of LACC
NCT06055738Locally Advanced Cervical Cancer
Tang-Du Hospital
Phase 2
20
Xi'an
2023-10-09
Recruiting
Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.
NCT05609630Juvenile Idiopathic Arthritis
AbbVie
Phase 3
90
Chongqing, Suzhou, Xi'an, Shanghai, Hangzhou
2023-10-02
Recruiting
Effect of Questionnaires and Feedback on the Patient Compliance for Endoscopic Surveillance After ESD
NCT06092281Patient Compliance
Xijing Hospital of Digestive Diseases
Not applicable
500
Xi'an
2023-10-01
Recruiting
Effect of Platelet-rich Plasma (PRP) Injection on Knee Osteoarthritis
NCT06082531Platelets-rich Plasma, Osteoarthritis Knees Both, Meniscus Disorder, Cartilage Injury
Xijing Hospital
Not applicable
300
Xi'an
2023-09-01
Recruiting
GNT Induction Treatment in Locally Advanced NPC
NCT06026878Nasopharyngeal Carcinoma
Air Force Military Medical University, China
Phase 3
228
Xi'an
2023-09-01
Not yet open
Efficacy and Safety of Disitamab Vedotin Plus Pyrotinib or Naratinib in HER2-positive Breast Cancer Patients With Brain Metastasis
NCT06015113Breast Cancer
Xi'an International Medical Center Hospital
Not applicable
20
Xi'an
2023-09
Active, closed
A Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy (nHCM)
NCT06081894Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy
Cytokinetics
Phase 3
500
Guangzhou, Beijing, Jilin City, Nanjin, Shanghai, Shenyang, Wuhan, Xi'an
2023-08-31
Recruiting
Risk Stratification Value of Biomarkers in Patients With Myocarditis
NCT06010199Myocarditis
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-08-25
Active, closed
Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis
NCT06174402Primary Biliary Cholangitis
Han Ying
Phase 2/3
184
Lanzhou, Guangzhou, Nanjing, Shenyang, Xi'an, Yan’an, Kunming, Beijing
2023-08-21
Active, closed
Study of XGEVA® (Denosumab) in Chinese Adults and Skeletally Mature Adolescents With Giant Cell Tumor of the Bone
NCT04586660Giant Cell Tumor of Bone
Amgen
Phase 4
36
Beijing, Fuzhou, Guangzhou, Harbin, Xi'an, Hangzhou
2023-08-17
Recruiting
The Role of Extracellular DNA (ecDNA) in the Occurrence and Development of Gastric
NCT05956847Gastric Cancer, Precancerous Lesion of Digestive Tract, Extrachromosomal DNA
Xijing Hospital
Observational
1,000
Xi'an
2023-08-10
Active, closed
Vepdegestrant (ARV-471/PF-07850327) + Palbociclib vs Letrozole + Palbociclib in ER(+)/HER2(-) Advanced Breast Cancer
NCT05909397Breast Cancer
Pfizer
Phase 3
59
Beijing, Guangzhou, Wuhan, Xi'an
2023-08-09
Recruiting
Exploratory Clinical Trial of Safety and Efficacy of Sacral Nerve Stimulation in Patients With Ulcerative Colitis.
NCT05895981Ulcerative Colitis
Xijing Hospital
Not applicable
15
Xi'an
2023-07-20
Recruiting
Low-dose NOAC Versus GDMT After LAAO
NCT05960721Atrial Fibrillation
Xijing Hospital
Not applicable
4,220
Xi'an
2023-07-06
Recruiting
Long-term Success Rate of Transvaginal Mesh for the Treatment of Pelvic Organ Prolapse: The Extended RCT Study
NCT05938881Pelvic Organ Prolapse
Peking Union Medical College Hospital
Observational
336
Foshan, Guangzhou, Changsha, Wuxi, Jinan, Xi’an, Chengdu, Ürümqi
2023-06-29
Recruiting
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
NCT05797168Ovarian Cancer, Lung Adenocarcinoma, Endometrial Cancer, Lung Squamous Cell Carcinoma
AstraZeneca
Phase 1/2
602
Chengdu, Chongqing, Guangzhou, Jinan, Xi'an, Zhengzhou
2023-06-05
Recruiting
A Phase II Clinical Trial of DZD9008 in Combination With AZD4205 in Standard Treatment Failed NSCLC Patients With EGFR Mutations (WU-KONG21)
NCT06295432Non-small Cell Lung Cancer
Dizal Pharmaceuticals
Phase 2
90
Guangzhou, Wuhan, Xi'an, Zhengzhou
2023-06-01
Recruiting
Prediction of Lymph Node Metastasis in Patients With Thyroid Malignancy by a New Scale
NCT06286631Papillary Thyroid Cancer
Second Affiliated Hospital of Xi'an Jiaotong University
Observational
800
Xi'an
2023-05-01
Recruiting
Efficacy and Safety of Head Acupuncture After Mechanical Thrombectomy for Acute Ischemic Stroke
NCT05561088Acupuncture, Acute Ischemic Stroke, Mechanical Thrombectomy
Xi'an No.3 Hospital
Not applicable
272
Xi'an
2023-04-27
Recruiting
Prognosis of Heart Transplanted Patients With Heart Failure
NCT05775432Heart Failure
First Affiliated Hospital Xi'an Jiaotong University
Observational
1,000
Xi'an
2023-04-23
Recruiting
Efficacy and Safety of Penpulimab Combined With Anlotinib and Chemotherapy
NCT06586242Esophageal Cancer
Xijing Hospital
Phase 2
194
Xi'an
2023-04-03
Active, closed
fMRI Study of the Neural Mechanism of rTMS in the Treatment of Nicotine Dependence
NCT06762535Tobacco Use Disorder, Repetitive Transcranial Magnetic Stimulation
Tang-Du Hospital
Not applicable
50
Xi'an
2023-04-01
Active, closed
A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
NCT05627557Childhood Idiopathic Nephrotic Syndrome
Hoffmann-La Roche
Phase 3
85
Beijing, Guangzhou, Hangzhou, Wuhan, Xi'an, Zhengzhou
2023-03-29
Active, closed
Clinical Trial of the TQB2102 Injection in Patients With Advanced Cancers
NCT05735496Advanced Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
Phase 1
219
Fuzhou, Guangzhou, Harbin, Zhengzhou, Changsha, Nanjing, Shenyang, Xi'an
2023-03-09
Active, closed
Minocycline for Acute Ischemic Stroke Undergoing Endovascular Treatment Due to Basilar Artery Occlusion (MIST-B)
NCT05512910Ischemic Stroke, Acute, Minocycline, Endovascular Treatment, Basilar Artery Occlusion
Xijing Hospital
Phase 4
90
Xi'an
2023-03-04
Rows per page Showing 301–400 of 504
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 24 September 2026. https://priyalifescience.com/clinical-trials-china/city/xi-an?page=4

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 504 of those studies with a site in Xi’an.

How many clinical trials are recruiting in Xi’an?

314 of the 504 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 94 have not yet opened recruitment, 77 are active but closed to new participants, and 19 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.